GRPR and prostate carcinoma: In further work, the same group conjugated TPP derivatives to the C-terminal region of bombesin (BBN [7–14]) using different conjugation strategies including SPAAC, because this polypeptide can target the gastrin-releasing peptide receptor (GRPR), a protein that is overexpressed in several tumors, especially in human prostate cancer (PC-3) cells.